Jimenez-Murcia S, Granero R, Fernandez-Aranda F, Arcelus J, Aymami MN, Gomez-Pena M, Tarrega S, Moragas L, del Pino-Gutierrez A, Sauchelli S, Fagundo AB, Brewin N, Menchon JM. Predictors of outcome among pathological gamblers receiving cognitive behavioral group therapy. Eur Addict Res. 2015;21(4):169-78. doi: 10.1159/000369528
Farreny A, Aguado J, Ochoa S, Haro JM, Usall J. The role of negative symptoms in the context of cognitive remediation for schizophrenia. Schizophr Res. 2013 Oct;150(1):58-63.
Farreny A, Aguado J, Ochoa S, Huerta-Ramos E, Marsà F, López-Carrilero R, Carral V, Haro JM, Usall J. REPYFLEC cognitive remediation group training in schizophrenia: looking for an integrative approach. Schizophr Res. 2012 Dec;142(1-3):137-44. doi: 10.1016/j.schres.2012.08.035.
Graham CN, Mauskopf J, Lawson AH, Ascher-Svanum H, Bruhn D, Watson PR. Validating an industry-sponsored model comparing the cost-effectiveness of atypical antipsychotics in the treatment of schizophrenia. Schizophr Res. 2010 Apr 1;117(2-3):398-9.